Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation

BACKGROUND: Improving access to paediatric HIV treatment requires both large-scale treatment programmes and medication that is adapted to infants and children's needs. The WHO recommends lopinavir/ritonavir as first-line antiretroviral therapy for all HIV-infected children younger than 3 years....

Descripción completa

Detalles Bibliográficos
Autores principales: Nebot Giralt, Ariadna, Nöstlinger, Christiana, Lee, Janice, Salami, Olawale, Lallemant, Marc, Ouma, Onyango, Nyamongo, Isaac, Marchal, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Research Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372016/
https://www.ncbi.nlm.nih.gov/pubmed/28360249
http://dx.doi.org/10.1136/bmjopen-2016-014528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372016/
https://www.ncbi.nlm.nih.gov/pubmed/28360249
http://dx.doi.org/10.1136/bmjopen-2016-014528

Ejemplares similares